DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Sepsis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Sepsis (129)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 129   Next >>

Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: male, weighing 77.2 kg (169.8 pounds)

Reactions: Sepsis, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
CC-4047
    Dosage: 4 milligram
    Administration route: Oral
    Start date: 2012-05-04
    End date: 2012-05-08

CC-4047
    Dosage: 4 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-12
    End date: 2012-04-16

CC-4047
    Dosage: 2 milligram
    Administration route: Oral
    Start date: 2012-05-08

CC-4047
    Dosage: 2 milligram
    Administration route: Oral
    Start date: 2012-04-27

Clarithromycin
    Dosage: 1000 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-12

Dexamethasone

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-12

Revlimid
    Dosage: 5 milligram
    Administration route: Oral

Other drugs received by patient: Atenolol; Hydrocortisone; Omega-3 Fatty Acids; Potassium Chloride; Atorvastatin Calcium; Metformin HCL; Amlodipine; Vasotec; Glyburide; Zometa; Prilosec; Magnesium Oxide; Niaspan; Tylenol; Actos; Imodium; Valtrex; Aspirin; Darbepoetin Alfa-Polysorbate; Feosol; Hydrocortisone



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Off Label Use, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: on day 1 over 15-30 minutes
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Sepsis, Hypoxia, Pleural Effusion

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Sepsis, Hypoxia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: male

Reactions: Pneumonia, Sepsis, Hypoxia, Mastoiditis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 4 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-04-04

Dexamethasone
    Dosage: 4 mg, cyclic
    Start date: 2012-05-01

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Administration route: Oral
    Start date: 2012-05-01

Velcade
    Dosage: 1 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-04-04

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Start date: 2012-04-04

Other drugs received by patient: Epogen; Neupogen; Blood and Related Products; Levaquin; Lithium Carbonate; Amitriptyline HCL; Platelets; Vfend; Acyclovir; Androderm



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: on day 1 over 15-30 minutes
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in 73 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-10

Patient: 73 year old female

Reactions: Neutropenic Sepsis, Sepsis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-26
    End date: 2012-07-26

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-26
    End date: 2012-07-22

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-26
    End date: 2012-07-01



Possible Dexamethasone side effects in female

Reported by a physician from United Kingdom on 2012-08-07

Patient: female

Reactions: Sepsis, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 100mgm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-21

Cytarabine
    Dosage: 4gm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-22

Dexamethasone
    Dosage: 40mg every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-21

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-20



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient:

Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: female

Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Left Ventricular Hypertrophy, Toxic Nodular Goitre, Nasal Congestion, Oesophageal Rupture, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Osteoporosis, Folliculitis, Fall, Gastric Ulcer, Haematemesis, Hyperparathyroidism, Chest Pain, Aortic Arteriosclerosis, Perineurial Cyst, Thyroid Mass, Depression, Decreased Appetite, Renal Failure Acute, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Syncope, Pulmonary Valve Incompetence, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Dysaesthesia, Gait Disturbance, Respiratory Tract Infection, Leukopenia, Vitamin D Deficiency, Weight Decreased, Goitre, Lower Limb Fracture, Herpes Zoster, Hypomagnesaemia, Uterine Leiomyoma, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Chest Discomfort, Stomatitis, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Sinusitis, RIB Fracture, Polyp, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actos
    Dosage: 30 mg, qhs
    Indication: Diabetes Mellitus

Aredia
    Dosage: 90 mg, qmo over 4 hrs
    Indication: Multiple Myeloma
    Start date: 2001-10-01
    End date: 2002-01-01

Aredia
    Start date: 2008-07-07

Dexamethasone

Zometa
    Dosage: 4 mg, q2mo infusion over 25 mins every other month
    Indication: Multiple Myeloma
    End date: 2005-07-21

Other drugs received by patient: Cytoxan; Aspirin; Prednisone; Hepatitis B Vaccine; Velcade; Procrit / 00909301 /; Cyclophosphamide; Alkeran; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Pneumovax 23; Enalapril Maleate; Norvasc; Revlimid; Decadron Phosphate; Chemotherapeutics NOS; Vincristine + Adriamycin + Dexamethasone; Pentamidine; Potassium Chloride; Thalidomide; Polio-Vaccine; Melphalan Hydrochloride; Fortamet; Crestor; Magnesium Oxide; Xanax; Benadryl; Doxil; Avalide; Influenza Vaccine; Augmentin '125'; Metformin Hydrochloride



Possible Dexamethasone side effects in 24 year old female

Reported by a consumer/non-health professional from United States on 2012-07-30

Patient: 24 year old female, weighing 51.0 kg (112.2 pounds)

Reactions: Abdominal Pain, Hyperkalaemia, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Acidosis, Nephrolithiasis, Skin Discolouration, Ecchymosis, Clostridial Infection, Emphysema, White Blood Cell Count Decreased, Hypotension, Anaemia, Condition Aggravated, Soft Tissue Infection, Sepsis, Flank Pain, Colitis, Cardiac Arrest, Sinus Tachycardia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: last dose on 16jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Cytarabine
    Dosage: last dose:17jun12 route:intra ommya
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Dexamethasone
    Dosage: last dose:16jun12
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Doxorubicin HCL
    Dosage: last dose:17jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Filgrastim
    Dosage: last dose:18jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17
    End date: 2012-01-01

Leucovorin Calcium
    Dosage: last dose :21may12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Mesna
    Dosage: last dose:17jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Methotrexate
    Dosage: last dose:13jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Methylprednisolone
    Dosage: last dose:21may12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Sprycel
    Dosage: last dose on 26jun12
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Vincristine Sulfate
    Dosage: last dose:17jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30

Patient: male

Reactions: Neutropenic Infection, Fungal Infection, Sepsis, Bacterial Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Chlorambucil
    Dosage: from day 20 to 29
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: from day 1 to 4
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: on day 1 (and day 8 of cycle 1)
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11
    Indication: Mantle Cell Lymphoma



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30

Patient: male

Reactions: Fungal Infection, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 3

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 4

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 1
    Indication: Mantle Cell Lymphoma

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 2

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 2

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 3

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 4
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 1

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4

Rituximab
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 3

Rituximab
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 2

Rituximab
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 3
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 2

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 1



Possible Dexamethasone side effects in 70 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-19

Patient: 70 year old male

Reactions: Sepsis, Urinary Tract Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Administration route: Oral
    Start date: 2012-03-14
    End date: 2012-07-06

Dexamethasone
    Dosage: 20 milligram
    Administration route: Oral
    Start date: 2012-03-14
    End date: 2012-07-06

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-03-14
    End date: 2012-07-06



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-18

Patient: male

Reactions: Neutropenic Infection, Fungal Infection, Sepsis, Bacterial Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Chlorambucil
    Dosage: from day 20 to 29
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: from day 1 to 4
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: on day 1 (and day 8 of cycle 1)
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11
    Indication: Mantle Cell Lymphoma



Possible Dexamethasone side effects in male

Reported by a physician from Japan on 2012-07-18

Patient: male

Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-01-13
    End date: 2012-02-03

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-10
    End date: 2012-01-07

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-05-12
    End date: 2011-05-25

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-01

Prednisolone
    Dosage: 10 milligram
    Indication: Multiple Myeloma
    Start date: 2012-02-09
    End date: 2012-02-17

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-03-31
    End date: 2011-04-13

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-03-30

Prednisolone
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2012-02-08

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-04-13

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-09-06

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-09-14
    End date: 2011-10-03

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-22

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-31

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-01-25
    End date: 2012-02-11

Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17

Patient: male

Reactions: Fungal Infection, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 1
    Indication: Mantle Cell Lymphoma

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 2

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 3

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 4

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 1
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 3

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 2

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 4

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 2

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 3

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 2

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 3
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 1



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-07-16

Patient:

Reactions: Pulmonary Toxicity, Gastrointestinal Toxicity, Nephropathy Toxic, Anaemia, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Sepsis, Cardiotoxicity, Neutropenia, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: drug: ps 341 on d1, 4, 8 and 11 of cycle 1.
    Indication: Mantle Cell Lymphoma

Chlorambucil
    Dosage: d20 to d29. one cycle every 35 days.
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: from day 1 to 4.
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: continuous infusion for 4 days. form: infusion.
    Indication: Mantle Cell Lymphoma

Mabthera
    Dosage: day 1 (and day 8 for cycle 1).
    Indication: Mantle Cell Lymphoma



Possible Dexamethasone side effects in male

Reported by a physician from Canada on 2012-07-16

Patient: male, weighing 68.9 kg (151.6 pounds)

Reactions: Multi-Organ Failure, Lung Infection, Sepsis, Muscular Weakness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-06

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-04-06

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-04-20

Other drugs received by patient: Gabapentin; Metoprolol Tartrate; Acyclovir; Sevelamer; Combigan; Amiodarone HCL; Vancomycin; Lumigan



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from United States on 2012-07-16

Patient:

Reactions: Multi-Organ Failure, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytoxan
    Administration route: Oral
    Indication: Amyloidosis

Dexamethasone
    Administration route: Oral
    Indication: Amyloidosis

Lenalidomide
    Administration route: Oral
    Indication: Amyloidosis



Possible Dexamethasone side effects in female

Reported by a physician from United Kingdom on 2012-07-16

Patient: female

Reactions: Sepsis, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 100mgm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-21

Cytarabine
    Dosage: 4gm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-22

Dexamethasone
    Dosage: 40mg every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-21

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-20



Possible Dexamethasone side effects in female

Reported by a lawyer from United States on 2012-07-02

Patient: female

Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Toxic Nodular Goitre, Left Ventricular Hypertrophy, Nasal Congestion, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Folliculitis, Fall, Gastric Ulcer, Hyperparathyroidism, Aortic Arteriosclerosis, Thyroid Mass, Perineurial Cyst, Depression, Renal Failure Acute, Decreased Appetite, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Pulmonary Valve Incompetence, Syncope, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Gait Disturbance, Dysaesthesia, Respiratory Tract Infection, Leukopenia, Weight Decreased, Vitamin D Deficiency, Goitre, Lower Limb Fracture, Herpes Zoster, Uterine Leiomyoma, Hypomagnesaemia, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Stomatitis, Chest Discomfort, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Sinusitis, RIB Fracture, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actos
    Dosage: 30 mg, qhs
    Indication: Diabetes Mellitus

Aredia
    Dosage: 90 mg, qmo over 4 hrs
    Indication: Multiple Myeloma
    Start date: 2001-10-01
    End date: 2002-01-01

Aredia
    Start date: 2008-07-07

Dexamethasone

Zometa
    Dosage: 4 mg, q2mo infusion over 25 mins every other month
    Indication: Multiple Myeloma
    End date: 2005-07-21

Other drugs received by patient: Xanax; Procrit / 00909301 /; Pentamidine Isethionate; Crestor; Enalapril Maleate; Magnesium Oxide; Vincristine + Adriamycin + Dexamethasone; Aspirin; Augmentin '125'; Benadryl; Decadron; Thalidomide; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Avalide; Potassium Chloride; Influenza Vaccine; Melphalan Hydrochloride; Metformin HCL; Doxil; Alkeran; Fortamet; Chemotherapeutics NOS; Hepatitis B Vaccine; Cyclophosphamide; Cytoxan; Pneumovax 23; Polio-Vaccine; Revlimid; Velcade; Prednisone TAB; Norvasc



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Austria on 2012-07-02

Patient:

Reactions: Anaemia, Pulmonary Embolism, Sudden Death, Rash, Macular Oedema, Cardiac Disorder, Fatigue, Sepsis, Cardiac Arrest, Thrombocytopenia, Leukopenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 5.7143 milligram

Revlimid
    Administration route: Oral



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-26

Patient: male, weighing 68.0 kg (149.7 pounds)

Reactions: Humerus Fracture, Small Intestinal Obstruction, Dyspnoea, Tendon Rupture, Sepsis, Urinary Retention

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone

Velcade
    Dosage: 2.3 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-02-14
    End date: 2011-02-24

Other drugs received by patient: Cymbalta; Percocet; Wellbutrin; Advair Diskus 100 / 50; Centrum Silver / 01292501 /; Clonazepam; Calcium with Vitamin D / 00944201 /; Nexium; Aspirin; Lunesta; Magnesium Sulfate; Crestor; Oxycontin; Senna / 00142201 /; Proventil / 00139501 /



Possible Dexamethasone side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22

Patient: 67 year old male

Reactions: Sepsis, Pulmonary Oedema, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-05-30

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-05-30

Thalidomide
    Dosage: 50 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-05-30



Possible Dexamethasone side effects in female

Reported by a physician from United States on 2012-06-21

Patient: female, weighing 50.4 kg (110.9 pounds)

Reactions: Abdominal Pain Lower, Vomiting, Diarrhoea, Nausea, Sepsis, Ventricular Tachycardia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-24
    End date: 2012-03-13

Other drugs received by patient: Benazepril Hydrochloride; Ferrous Fumarate; Simvastatin; Amlodipine; Iron; Calcium; Aspirin; Cytoxan



Possible Dexamethasone side effects in female

Reported by a physician from United States on 2012-06-14

Patient: female, weighing 50.4 kg (110.9 pounds)

Reactions: Abdominal Pain Lower, Vomiting, Nausea, Diarrhoea, Sepsis, Ventricular Tachycardia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-24
    End date: 2012-03-13

Other drugs received by patient: Benazepril Hydrochloride; Simvastatin; Calcium; Iron; Ferrous Fumarate; Cytoxan; Amlodipine; Aspirin



Possible Dexamethasone side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-12

Patient: 67 year old male

Reactions: Sepsis, Pulmonary Oedema, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-05-30

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-05-30

Thalidomide
    Dosage: 50 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-05-30



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from Denmark on 2012-06-01

Patient:

Reactions: Neurotoxicity, Death, Sepsis, Haematotoxicity

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Central Nervous System Lymphoma

Cytarabine

Cytarabine
    Indication: Central Nervous System Lymphoma

Dexamethasone
    Indication: Central Nervous System Lymphoma

Ifosfamide
    Indication: Central Nervous System Lymphoma

Mabthera
    Indication: Central Nervous System Lymphoma

Methotrexate
    Indication: Central Nervous System Lymphoma

Temozolomide
    Indication: Central Nervous System Lymphoma

Vincristine
    Indication: Central Nervous System Lymphoma

Vindesine
    Indication: Central Nervous System Lymphoma



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014